Literature DB >> 19289969

Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan.

Faran Emmanuel1, Chris Archibald, Ali Razaque, Paul Sandstrom.   

Abstract

BACKGROUND: During a routine surveillance round, an extremely high prevalence of 51.3% was found among injecting drug users (IDUs) in Sargodha, a small town in Pakistan. This sharp increase of HIV among this group warranted an urgent need to explore the factors leading toward this explosion of HIV infection among IDUs at this very location to direct the policy makers in designing preventive activities, especially in the context of HIV prevention.
METHODS: In 2007, 400 current IDUs were recruited through multistage cluster sampling based on mapping studies. Participants provided dried blood spot samples for HIV testing and completed a questionnaire on demographic characteristics and sexual/drug injecting behaviors. Logistic regression was used to examine the independent association of multiple variables with HIV infection.
RESULTS: Of the 400 IDUs tested, 205 (51.3%) were HIV positive confirmed through enzyme-linked immunosorbent assay and Western blot. In multivariate analysis, geographical location of IDUs [adjusted odds ratio (aOR) 2.4 for IDUs located in the northern zone vs southern zone, 95% confidence interval (CI) 1.5 to 3.7], injected in groups (aOR 1.8, 95% CI 1.1 to 3.1), and sharing injecting paraphernalia with other IDUs (aOR 1.5, 95% CI 1.0 to 2.4) were strong correlates of HIV infection.
CONCLUSIONS: Effective outreach programs need to be developed to provide a comprehensive package of HIV prevention services to IDUs not reached by existing services, entry into drug abuse treatment and medical care needs to be facilitated, and essential legal and social services need to be provided with community participation.

Entities:  

Mesh:

Year:  2009        PMID: 19289969     DOI: 10.1097/QAI.0b013e31819906f3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

Review 1.  Toward a comprehensive approach to HIV prevention for people who use drugs.

Authors:  Brandon D L Marshall; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

3.  Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.

Authors:  Catherine S Todd; Abdul Nasir; M Raza Stanekzai; Katja Fiekert; M Zafar Rasuli; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2011-08-25

4.  High HIV incidence among persons who inject drugs in Pakistan: greater risk with needle sharing and injecting frequently among the homeless.

Authors:  Rab Nawaz Samo; Arshad Altaf; Ajmal Agha; Omrana Pasha; Shafquat Rozi; Ashraf Memon; Saleem Azam; Meridith Blevins; Sten H Vermund; Sharaf Ali Shah
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

5.  A no-brainer for ending AIDS: the case for a harm reduction decade.

Authors:  Catherine Cook; Rick Lines; David P Wilson
Journal:  J Int AIDS Soc       Date:  2016-04-20       Impact factor: 5.396

6.  Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdul Nasir; Mohammad Raza Stanekzai; Katja Fiekert; Heather L Sipsma; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2015-10-16

7.  HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs.

Authors:  Guy Morineau; Liesbeth Jm Bollen; Rizky Ika Syafitri; Nurjannah Nurjannah; Dyah Erti Mustikawati; Robert Magnani
Journal:  Harm Reduct J       Date:  2012-09-03

8.  Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.

Authors:  R Stefan Ross; Oumaima Stambouli; Nico Grüner; Ulrich Marcus; Wei Cai; Weidong Zhang; Ruth Zimmermann; Michael Roggendorf
Journal:  Virol J       Date:  2013-03-05       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.